SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Healthcare, pharma stocks gain despite weakness over Dalal Street

23 Dec 2022 Evaluate

Stocks related to healthcare and pharmaceutical sector were trading higher on the BSE despite weakness over the Dalal Street, following the news of a resurgence of COVID-19 infections in China.

Shilpa Medicare is currently trading at Rs. 292.55, up by 24.45 points or 9.12 % from its previous closing of Rs. 268.10 on the BSE.

Thyrocare Technologies is currently trading at Rs. 652.05, up by 27.90 points or 4.47 % from its previous closing of Rs. 624.15 on the BSE.

Granules India is currently trading at Rs. 334.95, up by 7.60 points or 2.32 % from its previous closing of Rs. 327.35 on the BSE.

Aarti Drugs is currently trading at Rs. 457.60, up by 9.75 points or 2.18 % from its previous closing of Rs. 447.85 on the BSE.

Shilpa Medicare Share Price

416.50 -3.40 (-0.81%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×